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Abstract
N6-methyladenosine (m6A) regulates a variety of physiological
processes through modulation of RNA metabolism. This modifi-
cation is particularly enriched in the nervous system of several
species, and its dysregulation has been associated with neurode-
velopmental defects and neural dysfunctions. In Drosophila, loss of
m6A alters fly behavior, albeit the underlying molecular mecha-
nism and the role of m6A during nervous system development have
remained elusive. Here we find that impairment of the m6A path-
way leads to axonal overgrowth and misguidance at larval neuro-
muscular junctions as well as in the adult mushroom bodies. We
identify Ythdf as the main m6A reader in the nervous system, being
required to limit axonal growth. Mechanistically, we show that the
m6A reader Ythdf directly interacts with Fmr1, the fly homolog of
Fragile X mental retardation RNA binding protein (FMRP), to inhibit
the translation of key transcripts involved in axonal growth regula-
tion. Altogether, this study demonstrates that the m6A pathway
controls development of the nervous system and modulates Fmr1
target transcript selection.
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Introduction
Chemical modifications on DNA and histones impact gene expres-
sion during cell differentiation, organismal development, and in
several other biological programs (Jaenisch & Bird, 2003). Similarly,
RNA modifications are an important, recently characterized layer of
gene regulation but their functional characterization during develop-
ment and in other biological/pathological processes is still in its
infancy (Hsu et al, 2017).
N6-methyladenosine (m6A) is the most prevalent modification
found in mRNAs and long non-coding RNAs. The mark is widely
conserved, enriched in mRNAs at the beginning of the last exons, in
the sequence context RRACH (where R = A or G and H = A, C, or
U) (Dominissini et al, 2012; Meyer et al, 2012; Ke et al, 2015;
Garcia-Campos et al, 2019). m6A plays a central role in modulating
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RNA function, since it can influence many aspects of RNA life such
as splicing, export, translation, and decay (Roignant & Soller, 2017;
Zhao et al, 2017). m6A deposition is operated by a multisubunit
methyltransferase complex, composed of METTL3 and METTL14, as
well as several associated components (reviewed in ref. Lence et al,
2019). The m6A signature is subsequently recognized by “reader”
proteins, among which the best described is the YTH domain family
of proteins that decode the signal and mediate m6A biological effects
(Liao et al, 2018; Patil et al, 2018).
Increasing evidence suggests a central role of m6A during
nervous system development and functions (Angelova et al, 2018;
Jung & Goldman, 2018; Widagdo & Anggono, 2018; Du et al, 2019;
Li et al, 2019; Livneh et al, 2020). m6A is present at particularly high
levels in the nervous system of different model animals (Meyer
et al, 2012; Lence et al, 2016), and these levels can vary following
behavioral stimuli or sensory experience (Widagdo et al, 2016;
Engel et al, 2018; Koranda et al, 2018; Yoon et al, 2018). In mouse,
m6A controls brain development (Li et al, 2017; Li et al, 2018; Ma
et al, 2018; Wang et al, 2018; Chen et al, 2019; Zhuang et al, 2019)
and is also required for axon regeneration (Weng et al, 2018) and
synaptic functions (Engel et al, 2018; Koranda et al, 2018; Merkurjev
et al, 2018; Shi et al, 2018; Yu et al, 2018). Similarly, in Drosophila,
m6A promotes flight and locomotion via a neuronal function
(Haussmann et al, 2016; Lence et al, 2016; Kan et al, 2017; Lence
et al, 2017). A proper level of m6A appears critical for regulating
axonal growth as Mettl3 knock out (KO) in Drosophila has been
associated with axonal overgrowth at neuromuscular junctions
(NMJs) (Lence et al, 2016), and conversely, higher m6A (or m6Am)
produced by the loss of FTO, leads to shorter axonal length in
mouse dorsal root ganglia neurons (Yu et al, 2018). To date, the
underlying mechanism of m6A in axonal growth has remained
elusive.
Fragile X mental retardation protein (FMRP) is a polyribosome-
associated RNA binding protein (RBP) that negatively regulates the
translation of a subset of dendritic mRNAs (Laggerbauer et al, 2001;
Li et al, 2001; Darnell et al, 2011; Jacquemont et al, 2018). Additional
functions in splicing, export, and mRNA stability have also been
reported for this RBP (Davis & Broadie, 2017). The loss of FMRP is
the genetic cause of Fragile X syndrome (FXS), the most common
inherited form of intellectual disability and autism, with an esti-
mated prevalence of 1 in 4,000 males and 1 in 8,000 females (Garber
et al, 2006; Rousseau et al, 2011; Bagni & Zukin, 2019). Previous
high-throughput studies identified only short consensus sites for
FMRP binding (ACUK, WGGA, GAC sequences; K = G or U, W = A
or U), suggesting that additional elements provide the binding speci-
ficity (Suhl et al, 2014). Intriguingly, FMRP was recently identified as
a putative m6A reader in mammalian cells via unbiased proteomics
studies (Arguello et al, 2017; Edupuganti et al, 2017). Furthermore,
FMRP target mRNAs were shown to largely overlap with methylated
transcripts (Chang et al, 2017), and FMRP was found to modulate
their export to the cytoplasm (Edens et al, 2019; Hsu et al, 2019), as
well as their stability (Zhang et al, 2018). These studies indicate roles
for FMRP in modulating m6A function in the nervous system.
However, the physiological relevance of this crosstalk in the context
of the FXS has yet to be evaluated. Moreover, it remains to be deter-
mined how FMRP interplays with other m6A readers.
In the present study, we seek to obtain mechanistic insights into
the role of m6A in Drosophila neurodevelopment. We found that, in
addition to controlling axonal growth at neuromuscular junctions
(NMJs), m6A prevents axonal crossing and b-lobe fusion of the
neurons in the mushroom bodies (MBs), a higher hierarchy circuit
of the central brain implicated in a wide range of fly behaviors,
including learning and memory. By using an unbiased approach to
identify m6A readers in the Drosophila nervous system, we demon-
strate that Ythdf, the unique cytoplasmic YTH protein in Drosophila,
recognizes methylated transcripts and mediates m6A function in
restricting axonal growth. We further show that Ythdf directly inter-
acts with Fmr1, the Drosophila FMRP homolog, and modulates its
binding activity. Ythdf and Fmr1 share common targets related to
nervous system development and act in concert to inhibit the trans-
lation of positive regulators of axonal growth. Thus, this study
demonstrates that Fmr1 function in axonal growth is modulated by
its interaction with the m6A reader Ythdf, providing mechanistic
insight on this interplay and possibly novel avenues for therapeutic
approaches of the FXS.
Results
m6A restricts axonal growth at the peripheral and central
nervous system
Previous studies demonstrated that m6A controls several aspects of
neuronal development and behavior in Drosophila melanogaster
(Haussmann et al, 2016; Lence et al, 2016; Kan et al, 2017). In
particular, flies lacking Mettl3 are flightless and have reduced speed
and orientation defects (Lence et al, 2016). Furthermore, an
increased number of synaptic boutons was detected at mutant
NMJs. To confirm and extend this initial analysis, we dissected addi-
tional alleles of Mettl3, as well as of Mettl14, and scored the number
of synapses, branches, and the overall size of the axons. Consistent
with our previous report, we observed an augmentation of synaptic
bouton number of about 40% to 50%, depending on Mettl3 allelic
combinations (Fig EV1A and Appendix Fig S1). Furthermore, Mettl3
mutants displayed significant axonal overgrowth and over-elabora-
tion of synaptic terminals (Figs 1C and D, and EV1B and C). Impor-
tantly, all these defects were completely rescued upon ubiquitous
expression of Mettl3 cDNA. Consistent with Mettl3 loss-of-function
phenotypes, the Mettl14 KO gave identical defects (Fig 1A–D). Thus,
these results indicate that m6A is required for normal NMJ synaptic
architecture in Drosophila.
We next asked whether m6A was also required for the integrity
of the central nervous system (CNS). We dissected adult brains of
control and fly mutants for the m6A pathway and examined the
structure of MBs. Compared to wild-type flies, the MBs of Mettl3
and Mettl14 KOs exhibited midline crossing and fusion of the b
lobes (Fig 1E). The penetrance varied from 37% to 73%, depend-
ing on the alleles (Fig 1F). A similar defect was observed upon
inactivation of Mettl3 or Mettl14 specifically in the MB using RNAi
(Fig EV1D and E), suggesting a cell-autonomous requirement of
m6A. Furthermore, expression of Mettl3 cDNA either ubiquitously,
pan-neuronally, or in the MBs only, was sufficient to rescue the b
lobe overgrowth, confirming the specificity and the cell-autono-
mous nature of the phenotype (Fig 1E and F). We conclude that
m6A limits axonal growth in the peripheral and central nervous
system.
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Fmr1 and Ythdf bind to methylated sites with
different specificity
To decipher the mechanisms underlying the role of the m6A path-
way in the nervous system, we aimed to identify the proteins that
mediate m6A function in this tissue. We carried out RNA pulldowns
in Drosophila neuronal cell lysates followed by quantitative mass
spectrometry-based proteomics, as described before (Edupuganti
et al, 2017). Briefly, a methylated RNA probe containing four
repeats of the m6A consensus sequence GGACU was mixed with
lysates from BG3 cells, which were derived from the larval CNS (Ui
et al, 1994). As control, we used the same probe lacking the methy-
lation. After pulldown, bound proteins were subjected to trypsin
digestion and analyzed by liquid chromatography–tandem mass
spectrometry (LC-MS/MS). Using this approach, we identified eight
proteins that were significantly enriched with the methylated probe
(Fig 2A and Dataset EV1). As anticipated, the two YTH domain-
containing proteins were among the most strongly enriched.
Furthermore, we also found Fmr1, whose mammalian homolog was
similarly shown to preferentially bind a methylated probe (Arguello
et al, 2017; Edupuganti et al, 2017).
Given that binding of Ythdc1 to a methylated probe was already
confirmed in vitro (Kan et al, 2017), we further aimed to address
whether Ythdf and Fmr1 bear the same specificity. Therefore, we puri-
fied recombinant GST-tagged Ythdf as well as His-tagged Fmr1 lacking
the first 219 N-terminal amino acids (as the full-length version is very
unstable, also described in (Chen et al, 2014)) and tested their ability






Figure 1. m6A regulates axonal growth and guidance in the Drosophila nervous system.
A Representative confocal images of muscle-6/7 NMJ synapses of abdominal hemisegments A2–A3 for the indicated genotypes labeled with anti-synaptotagmin
(green) and HRP (red) to reveal the synaptic vesicles and the neuronal membrane. Scale bar: 20 lm.
B–D Quantification of normalized bouton number ((B), total number of boutons/muscle surface area (lm2 × 1,000)), normalized axon length (C), and normalized
branching (D) of NMJ 6/7 in A2–A3 of the indicated genotypes. Bars show mean  s.e.m. Multiple comparisons were performed using one-way ANOVA with a post
hoc Sidak–Bonferroni correction. (n.s. = not significant; *P < 0.05; ***P < 0.001; ****P < 0.0001).
E Immunofluorescence analysis of adult brains for the indicated genotypes using anti-Fascilin II (FasII) antibody to visualize lobes of the MB. Pink dashed lines
highlight the normal and fused b-lobes. Scale bar 50 lm.
F Quantification of the penetrance of fusion phenotype in the indicated genotypes.
Data information: In (B–D, F), bars are labeled with the number of replicates.
Source data are available online for this figure.
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cell lysates, we found that both purified GST-Ythdf and His-Fmr1
bound preferentially to the methylated probe (Fig 2B and C). By incu-
bating RNA probes with different concentrations of purified proteins,
we found that the binding of Ythdf was highly specific at all used
concentrations. In contrast, binding of Fmr1 was only slightly
enriched in the m6A probe pulldown, as compared to the pulled down
in the absence of methylation. Interestingly, the specificity for the m6A
modified probe decreased with high level (16pmol) of either protein.
We also tested the binding behavior on RNA probes containing
repeats of the alternative m6A consensus AAACU. In this case, Fmr1
displayed no specific binding to neither the methylated probe nor
the non-methylated probe. Ythdf still bound with higher specificity
the methylated probe, though a milder background binding to the
unmethylated probe was also observed (Fig EV2). We confirmed
this result by performing fluorescence polarization assays using Cy5
labeled RNA probes and calculated the binding constants of the
Ythdf/Fmr1 RNA interaction (Fig 2D). While a strong binding of
Ythdf to the m6A probe (Kd = 35 nM) could be determined, no bind-
ing to the unmethylated probe was observed. In line with the previ-
ous findings, Fmr1 did not bind any of the probes. We conclude that
the binding of Fmr1 to m6A consensus sequences is largely
sequence-dependent, which is in line with previous pulldown exper-
iments in human cells (Edupuganti et al, 2017) and with a recent
study showing that only a fraction of methylated sites is recognized
by human FMRP (Hsu et al, 2019).
Fmr1 and Ythdf limit axonal growth
The Fmr1 loss of function was previously shown to give over-




Figure 2. Ythdf and Fmr1 binding behavior to methylated RNA probes.
A Results of m6A RNA pulldown in BG3 protein cell extracts. Pulldown were performed using biotinylated probes containing four m6A consensus sites (GGACU), with
or without the methylation. The P-value is calculated from a two-sided t-test with unequal variants (Welch t-test). Dashed lines represent log10 P-value = 1 as
well as log2 enrichment = 1. m
6A-enriched proteins (log10 P-value > 1 and log2 enrichment > 1) are depicted by bigger dots.
B, C Western blot showing the protein enrichments upon pulldown of the same probes as in (A) incubated with increasing concentrations of purified recombinant GST-
Ythdf (B) and His-NT-Fmr1 proteins (C). Quantification of the m6A/A signal intensity is shown below the blot as median  SEM of the triplicates. Both proteins
bind more efficiently upon methylation.
D Results of fluorescence polarization (FP) assay using Cy5 labeled RNA probes containing four AAACU m6A consensus sites, with or without the methylation,
incubated with GST-Ythdf and His-NT-Fmr1. The relative FP values from three independent experiments including standard deviation were plotted using GraphPad
Prism 8. Binding constants (kd values) were determined by fitting a Michaelis–Menten non-linear regression onto the relative FP values in GraphPad Prism 8, if
applicable. The respective binding constants are given in the table next to the graphs.
Source data are available online for this figure.
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S2 and Zhang et al, 2001; Michel et al, 2004), suggesting that it
could mediate the m6A axonal growth function. To address
whether Ythdc1 and/or Ythdf also control NMJ morphology, we
dissected third instar larvae carrying mutations in the Yth genes.
Using our previously described Ythdc1 allele combined over a
deficiency line spanning the locus, we did not detect any gross
morphological defect (Fig 3A–D). To address the contribution of






Figure 3. Ythdf and Fmr1 interact genetically to control axonal growth.
A Representative confocal images of muscle-6/7 NMJ synapses of abdominal hemisegments A2-A3 for the indicated genotypes labeled with anti-synaptotagmin
(green) and HRP (red) to reveal the synaptic vesicles and the neuronal membrane. Scale bar: 20 lm.
B–D Quantification of normalized bouton number ((B), total number of boutons/muscle surface area (lm2 × 1,000)), normalized axon length (C), and normalized
branching (D) of NMJ 6/7 in A2-A3 of the indicated genotypes. Bars show mean  s.e.m. Multiple comparisons were performed using one-way ANOVA with a post
hoc Sidak–Bonferroni correction (n.s. = not significant; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001).
E Immunofluorescence analysis of adult brains for the indicated genotypes using anti-Fascilin II (FasII) antibody to visualize lobes of the MB. Pink dashed lines
highlight the normal and fused b-lobes. Scale bar 50 lm.
F Quantification of the penetrance of fusion phenotype in the indicated genotypes.
G Quantification of normalized bouton number (total number of boutons/muscle surface area (lm2 × 1,000)), of NMJ 6/7 in A2-A3 of the indicated genotypes. Bars
show mean  s.e.m. Multiple comparisons were performed using one-way ANOVA with a post hoc Sidak–Bonferroni correction (n.s. = not significant; *P < 0.05;
**P < 0.01; ***P < 0.001; ****P < 0.0001).
Data information: In (B–D, F, G), bars are labeled with the number of replicates.
Source data are available online for this figure.
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approach (Appendix Fig S1). Examination of the NMJs in the
trans-heterozygote flies revealed significant overgrowth compared
to control flies (Fig 3A–D). Thus, these results indicate that in
addition to Fmr1, Ythdf may also contribute to the m6A-depen-
dent regulation of NMJ morphology.
To address the role of YTH proteins in the CNS, we dissected
adult brains of control and fly mutants for the respective Yth genes
and examined the MB structure. Compared to control flies, Ythdf KO
brains show a substantial fusion of the b lobes (55%), mimicking
the loss of Mettl3 and Mettl14 (Fig 3E and F). This defect was
rescued upon Ythdf re-expression. In contrast, the lack of Ythdc1
displayed no visible defect. Altogether, these results indicate that
the m6A pathway controls axonal growth, both at NMJs and MBs,
possibly via Fmr1 and Ythdf.
Ythdf interacts physically and genetically with Fmr1
To address how Ythdf prevents overgrowth at NMJs and MBs, we
searched for co-factors using stable isotope dimethyl labeling-based
quantitative proteomics upon immunoprecipitation of Flag-tagged
Ythdf from S2R+ cells, which is an embryonic derived cell line. We
identified 51 factors that showed more than two-fold enrichment in
the Flag-Ythdf pulldown fraction in comparison to a control pull-
down (Appendix Fig S3A and Dataset EV2). The co-purified proteins
were especially enriched for RNA binding proteins and translation
regulators (Appendix Fig S3B). Interestingly, Fmr1 was among the
20 most enriched proteins (Fig 4A). In fact, several proteins previ-
ously shown to interact with Fmr1 were also pulled down with Flag-
Ythdf (Fig 4A, highlighted in bold; Ishizuka et al, 2002; Sahoo et al,
2018; Xu et al, 2013), suggesting that Ythdf may be part of a whole
Fmr1 complex.
To validate the co-existence of Ythdf and Fmr1 in the same
complex, we performed co-immunoprecipitation assays in S2R+ cells
ectopically expressing Flag-Myc-tagged Ythdf and Myc-tagged Fmr1
in the presence of Benzonase. Notably, these experiments confirmed
that Fmr1 and Ythdf co-precipitate, independently of RNA (Fig 4B).
To next address whether these two proteins interact directly, we
tested whether purified recombinant GST-tagged Ythdf and Fmr1
A B
C D
Figure 4. Fmr1 and Ythdf physically interact and share common targets.
A Heatmap indicating the normalized forward versus inverted reverse experiment enrichments on a log2 scale of quantitative proteomics upon pulldown of Flag-
tagged Ythdf in S2R+ cells. The threshold was set to a 1-fold enrichment. Fmr1 is co-purified with Ythdf. Known Fmr1 interacting proteins are highlighted in bold
with asterisk.
B Co-immunoprecipitation experiment in S2R+ cells co-expressing Flag-Myc-tagged Ythdf and Myc-tagged Fmr1. Ythdf was used as a bait via its Flag tag. The lysate
was treated with Benzonase as indicated to remove interactions enabled by RNA.
C GST pulldown of recombinant GST-Ythdf or GST alone mixed with recombinant 6xHis-NT-Fmr1. 2 µM of recombinant proteins were using during the pulldown. The
pulldown of the proteins was analyzed by CBB staining.
D Overlap of miCLIP dataset generated in S2R+ cells defining m6A modified transcripts with Fmr1 and Ythdf mRNA targets determined by TRIBE in S2R+ cells. The
indicated P-value was determined by hypergeometric test.
Source data are available online for this figure.
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proteins could pull down each other. As shown in Fig 4C, Fmr1
could be co-purified by pulling down GST-Ythdf but not GST alone,
indicating that Ythdf and Fmr1 directly interact.
To address whether Ythdf and Fmr1 interact to regulate axonal
growth at the NMJ, we performed epistasis experiments. While
single heterozygote larvae displayed normal NMJ architecture, we
found that double heterozygotes had a significant increase in the
number of synaptic boutons (Fig 3G, compare lanes 2 and 4 with
lane 6). Furthermore, the severity of the axonal growth defect
observed in each homozygote mutants was not increased by remov-
ing one or two copies of the other genes (Fig 3G, compare lanes 2
and 5 with lanes 7, 8 and 9). These epistasis experiments thus
suggest that both genes act in the same pathway to regulate the
NMJ phenotype.
Ythdf and Fmr1 regulate translation of similar targets
In order to identify Ythdf and Fmr1 mRNA targets, we used the
TRIBE approach, as previously described (Worpenberg et al, 2019).
Briefly, metal-inducible fusion constructs expressing Ythdf-cdAdar,
Fmr1-cdAdar, or cdAdar alone were transfected in S2R+ cells and
RNA was isolated for sequencing 2 days after the induction of the
constructs. Bound mRNA targets were identified by scoring A-I edit-
ing events obtained after comparison with unspecific events gener-
ated by cdAdar alone. Using a stringent cutoff, we identified 1209
Ythdf and 961 Fmr1 targets, with a significant degree of overlap
(n = 700, P = 1.14e-398; Fig 4D, Dataset EV3). To address whether
these targets were methylated, we performed miCLIP-seq using
S2R+ cell extracts. We identified 2,464 methylated transcripts (about
34% of expressed genes), with strong enrichment of m6A sites
within 5’ UTR, in the sequence context AAACA (Fig EV3A and B;
Dataset EV4). This profile is distinct from vertebrate and is consis-
tent with an earlier report (Kan et al, 2017). Among methylated
transcripts, 925 were common with Ythdf (76% of Ythdf targets)
and 615 with Fmr1 (64% of Fmr1 targets; Fig 4D). Even though
S2R+ cells do not have a neural origin, common methylated targets
were enriched for axon regeneration (Fig EV3C). Moreover, consis-
tent with the in vivo phenotypes, genes enriched for regulation
of microtubule depolymerization were overrepresented. Altogether,
these experiments identify common methylated targets for
Ythdf and Fmr1, confirming they could act together to regulate
gene expression.
To further understand the interplay between Ythdf and Fmr1 on
RNA, we repeated pulldown experiments using the aforementioned
biotinylated RNA probes. By combining a constant concentration of
His-Fmr1 with an increasing amount of GST-Ythdf, we found a
substantial increase of the Fmr1 binding to the methylated RNA
probe with higher Ythdf protein concentrations in the GGACU
sequence context (Fig 5A and B). Notably, the binding of Ythdf at
the respective concentration was not changed by the presence of
Fmr1 (Appendix Fig S4). The same trend could be observed for the
alternative AAACU sequence context. Adding purified GST-Ythdf
protein to His-Fmr1 protein enabled a specific enrichment of Fmr1
in the m6A probe pulldown fraction (Fig 5C). In addition, elec-
trophoretic mobility shift assay (EMSA) using the Cy5 labeled
AAACU RNA probes revealed a strong preference of Ythdf for
the methylated RNA probe, while Fmr1 did interact with neither the
methylated nor unmethylated probe (Fig 5D). Though, the
incubation of the RNA probe with a mixture of Fmr1 and Ythdf
caused a shift of the RNA–protein complex signal in comparison
with Ythdf alone, suggesting that Ythdf and Fmr1 bind together the
methylated probe. Hence, these results indicate that Ythdf can facili-
tate binding of Fmr1 to methylated sites.
This result led us to investigate whether Fmr1 binding to mRNA
is altered upon KO of Ythdf in vivo. To address this point, we
performed a RNA immunoprecipitation assay (RIP) of endogenous
Fmr1 from brain extracts of wt or Ythdf KO animals followed by
sequencing. The RIP assay identified 584 significant target tran-
scripts for the wild-type samples, corresponding to 487 genes
(Fig 5E and Dataset EV5). These genes recapitulated the known
functions associated with Fmr1, including nervous system develop-
ment and regulation of RNA metabolism (Appendix Fig S5). The RIP
assay in the Ythdf KO brains identified a similar number of target
transcripts, 585, corresponding to 480 genes. The overlap between
the two sets of targets is 57% (276 genes), with 211 and 204 genes,
respectively, unique to wt and Ythdf KO samples (Fig 5E). This
finding indicates that the binding specificity of Fmr1 is partially
reprogrammed in the Ythdf mutant. Since our data suggest that
Ythdf promotes Fmr1 binding to methylated transcripts, we
expected in the Ythdf KO a loss of Fmr1 binding to the targets
shared with Ythdf. We then analyzed the overlap between the genes
lost in the Ythdf KO sample, with the previously identified Ythdf
targets (Fig 4D), and we observed a significant overlap (P = 3.04E-
26) (Fig 5F). Interestingly, the 211 lost genes are enriched in
functions associated to neuronal development, including MB devel-
opment, synapse assembly, and axon guidance (Appendix Fig S5).
Collectively, these experiments led to the identification of
common methylated targets of Ythdf and Fmr1 and strongly suggest
that these two factors directly interact to regulate gene expression.
Ythdf and Fmr1 control axonal growth at the MB and inhibit chic
mRNA translation
Among the common targets of Fmr1 and Ythdf that are also methy-
lated were chickadee (chic) transcripts (Fig EV4A). chic codes for
Profilin, an actin-binding protein that modulates many processes
depending on actin dynamics, among these neuronal growth and
remodeling (Verheyen & Cooley, 1994). Importantly, previous work
by Reeve and colleague demonstrated that Fmr1 controls axonal
growth in the CNS via inhibition of chic translation (Reeve et al,
2005). We first performed an RNA immunoprecipitation assay (RIP)
to confirm the binding of Fmr1 and Ythdf to chic mRNA in the adult
fly brain using HA-tagged Ythdf and GFP-tagged Fmr1 driven by the
neuronal driver elav-GAL4. As shown in Fig EV4B, both proteins
were able to pulldown chic mRNA. To test whether the m6A path-
way regulates chic expression in a similar manner as Fmr1, we
examined Profilin protein levels using brain extracts from wild-type
and Ythdf mutant. We found that the lack of Ythdf led to increased
Profilin levels (Fig 6A and B). In contrast, chic mRNA levels
remained unaffected (Fig 6C). These results prompted us to investi-
gate whether the increased Profilin level was involved in the MB
b-lobe fusion phenotype. We then crossed Ythdf mutant to chic
mutant flies and scored for MB developmental defects. As shown in
Fig 6D and E, loss of one copy of chic was sufficient to rescue the
b-lobe fusion phenotype of Ythdf mutant flies. On the other hand,
chic heterozygote mutant flies already showed b-lobe fusion per se,
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suggesting that the level of Profilin has to be tightly regulated to
ensure proper brain wiring. Hence, our results suggest that Ythdf
interacts with Fmr1 to limit the axonal growth at the MB and inhibit
the translation of chic mRNA.
Ythdf and Fmr1 control axonal growth at the NMJ and inhibit
futsch mRNA translation
We next investigated whether chic could also be common effector of
Fmr1 and Ythdf at the NMJ. As in the adult brain, we found that
both proteins interact with chic mRNA in the larval nervous system
(Fig EV4C). However, in contrast to what we observed at the MB,
removing one copy of chic had no effect on the NMJ phenotype
produced by the loss of Ythdf (Fig EV4D). These results indicate that
chic is not involved in the m6A-dependent phenotype at the NMJ
and that other targets must be involved. To reveal their identity, we
generated transgenic flies expressing Ythdf-cdAdar under the control
of an UAS promoter. The construct was specifically expressed in
the nervous system of third instar larvae using the elav-GAL4





Figure 5. Ythdf modulates Fmr1 target selection.
A–D Pulldown of biotinylated RNA probes of (A) repetitive GGACU sequences incubated with 4 pmol His-NT-Fmr1 and increasing concentrations of GST-Ythdf and (B)
the respective quantification plotted as the median of the m6A/A signal intensity  SEM of three replicates. The indicated P-values were determined by unpaired,
two-tailed Student’s t-test. (C) AAACU sequences RNA probes incubated with either 32 pmol recombinant GST-Ythdf or/and 6xHis-NT-Fmr1. Pulled down proteins
were analyzed by immunoblotting using a-Ythdf and a-Fmr1 antibodies. (D) EMSA assay using purified GST-Ythdf and His-NT-Fmr1 proteins and RNA probes in
the AAACU sequence context.
E Intersection of Fmr1 RNA immunoprecipitation target genes for wild-type and Ythdf KO brains, displaying a considerable number of genes gained and lost with
Ythdf loss.
F Intersection of genes lost (i.e., bound in wild-type but not in Ythdf KO) with Ythdf target genes determined by a TRIBE assay. P-value calculated with
hypergeometric test.
Source data are available online for this figure.
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high-throughput sequencing. Using this strategy, we identified 982
Ythdf target mRNAs in larval brains (Dataset EV6). We found a
significant overlap with the Ythdf-TRIBE dataset produced in S2R+
cells (n = 373, P = 1.32e-64, Fig EV4E), which includes the chic
mRNA. Interestingly, we found that the futsch mRNA was scoring in
the first 5% of the targets identified in the larval brain (53th highest
TRIBE SumScore out of 982 mRNAs, Fig EV4F). futsch encodes a
microtubule-associated protein that is a key target of Fmr1 in the
regulation of axonal growth at the NMJ (Zhang et al, 2001). We con-
firmed the binding of Ythdf and Fmr1 to futsch mRNA in larval
brains by immunoprecipitating HA-tagged Ythdf and GFP-tagged
Fmr1 driven by the neuronal driver elav-GAL4 (Fig EV4C). Remark-
ably, in Mettl3 and Ythdf mutants Futsch protein level was signifi-
cantly upregulated at the larval NMJ and in larval brain extracts,
which is reminiscent of the previously described upregulation
observed in the Fmr1 mutant (Fig 7A–C). In contrast, futsch mRNA
level was downregulated by two-fold (Fig 7D). To discriminate
between a defect in translation inhibition and a defect in protein
decay, we performed Translating Ribosome Affinity Purification
(TRAP). By immunoprecipitation of a GFP-ribosomal fusion protein,
TRAP enables the isolation of mRNAs associated with at least one
ribosome, providing an estimation of the translation status of single
transcripts. We expressed RPL10-GFP in neurons using the elav-
GAL4 driver and pulled down associated RNA using an anti-GFP
antibody. Using this approach, we found that futsch mRNA was
strongly enriched in the Ythdf mutant, demonstrating that its trans-
lation was likely increased (Fig 7E). Altogether, these experiments
indicate that, like Fmr1, the m6A pathway restricts futsch mRNA
translation in the larval nervous system.
To functionally address the relationship between the m6A path-
way and futsch mRNA at the NMJ, we performed genetic experi-
ments. As shown earlier, the number of synapses in the Fmr1
mutant was restored to a normal level by removing futsch function
(Fig 7F lanes 1–3, Zhang et al, 2001). Similar rescues were obtained
in the Mettl3 and Ythdf mutants (Fig 7F, lanes 1, 4–7). This indi-
cates that the m6A pathway represses futsch mRNA translation,
which contributes to the control of axonal growth at the NMJ.
Ythdf binding to futsch mRNA 5´ UTR promotes
translation inhibition
To functionally investigate the mechanism underpinning the influ-
ence of m6A and of the Ythdf/Fmr1 complex on futsch translation,
we determined the location of the m6A sites on the futsch transcript.
By analyzing our miCLIP-seq data, we found that futsch harbors
two m6A sites in its 5´ UTR, close to the start codon (Fig 8A). We
verified the methylation of one of these sites in vivo by performing
single-base elongation and ligation-based qPCR amplification
(SELECT) (Xiao et al, 2018) using larval brain extract (Fig EV5A).
To next define the influence of the methylation on futsch expres-
sion, we designed reporters containing the GFP coding sequence
downstream of the WT futsch 5´ UTR or a version containing A-T
point mutations at the m6A sites (Fig 8B). We tested whether the
binding of Ythdf and Fmr1 to the mutated reporter transcript was
altered by immunoprecipitating Flag-tagged Ythdf and Fmr1 from
S2R+ cell lysate co-transfected with the wt or mutated reporter
constructs. While the wt GFP reporter was strongly enriched in the
Ythdf and Fmr1 pulldown fractions, a significantly lower amount of
the mutated GFP reporter transcript was recovered (Fig 8C), though
the input protein and GFP transcript levels were similar (Fig EV5B
and C). In addition, we found that the enrichment of the wt futsch
5´ UTR reporter, but not the mutated version, was significantly
increased in the Fmr1 pulldown fraction when Ythdf was co-
expressed (Figs 8D and Fig EV5D), indicating that Ythdf increases
the binding of Fmr1 to this reporter. We next analyzed whether
mutations of the two m6A sites led to a change in the translation
efficiency, similar to the observed increased translation of endoge-
nous futsch in Ythdf mutants. As shown in Fig 8E and F, the GFP
translation efficiency from the mutated reporter was significantly
increased in comparison with the WT reporter. A similar increase
of the translation efficiency could be observed for the wild-type
reporter upon depletion of Mettl3 (Fig 8E and F) or Ythdf (Fig 8G),
while no significant difference was observed for the mutated




Figure 6. Fmr1 and Ythdf regulate CNS axonal growth and Profilin levels.
A Representative Western blot analysis of protein extracts of late
pupae heads (85–95 h) from control, Ythdf#0/ Ythdf#0 and Fmr1Δ50/Fmr1Δ50
flies. The membranes were probed with anti-Profilin or anti-Actin
antibodies.
B Quantification of Profilin protein levels (mean  SD) obtained from three
independent protein extraction and Western blot analysis as in (A).
Quantification was performed using Fiji. **P < 0.005; *P < 0.05, measured
with unpaired t-test.
C Quantification of chic mRNA levels (mean  SD) obtained from six
independent RNA extractions from control, Ythdf#0/Ythdf#0 and Fmr1Δ50
late pupae heads, via real-time PCR analysis. Statistical analysis using
unpaired t-test show no significant difference between the samples.
D Immunofluorescence analysis of adult chic/+ and chic/+; Ythdf#0/Ythdf#0
using anti-FasII antibody. Scale bar: 50 lm. Pink dashed lines highlight the
normal and fused b-lobes.
E Quantification of the penetrance of b-lobe fusion phenotype for the
indicated genotypes. Bars are labeled with the number of replicates.
Source data are available online for this figure.
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futsch 5´ UTR harbors at least two m6A sites, which are required for
Ythdf and Fmr1 binding and for the translational repression of
futsch (Fig 8H).
Discussion
m6A on mRNA is emerging as a key modulator of nervous system
biology (for recent review see (Livneh et al, 2020)). Despite the
increasing amount of data associating m6A function to brain devel-
opment, neuronal differentiation, regeneration, and synaptic func-
tion, the molecular mechanisms underlying these functions remain
largely incomplete. Here we show that m6A is required for proper
neuronal development in both CNS and PNS, where it prevents MB
b-lobes fusion and NMJ overgrowth, respectively. We further
demonstrate a critical interplay between Ythdf and Fmr1 in the
control of axonal growth. We show that Ythdf can interact with
Fmr1 and inhibit the translation of critical targets that ensures
proper axonal growth and homeostasis. Hence, our study reports
that m6A can modulate Fmr1 target selectivity to influence the
development of the nervous system in Drosophila.
m6A in axon growth and guidance
Previous work showed that flies lacking m6A are flightless and have





Figure 7. Fmr1 and Ythdf regulate CNS axonal growth and inhibit Futsch translation.
A Representative confocal images of muscle-6/7 NMJ synapses of abdominal hemisegment A2 for the indicated genotypes labeled with HRP (red) and a-futsch (green)
to reveal the neuronal membrane and Futsch protein level. Scale bar: 20 lm.
B Quantification of normalized Futsch protein level at NMJ 6/7 in A3 of the indicated genotypes (n = 20). Bars show mean  s.e.m. P values were determined with a
Student’s t-test. (*P < 0.05; **P < 0.01; ****P < 0.0001).
C Western blot analysis of Futsch protein level in isolated third instar larval brains of different mutants compared to control. Numbers indicate normalized Futsch
protein level in comparison to Tubulin levels.
D Quantification of futsch mRNA levels obtained from isolated 3rd instar larvae brains of the indicated genotypes via real-time PCR analysis. Bars show average  SD of
biological triplicates.
E Translating Ribosome affinity purification assay. Quantification of futsch mRNA levels upon immunoprecipitation of GFP-tagged Rpl10Ab or GFP in wild-type and
Ythdf#0 3rd instar larvae with Real-time qPCR. Bars show average  SD of technical triplicates.
F Quantification of normalized bouton number (total number of boutons/muscle surface area (lm2 × 1,000)) of NMJ 6/7 in hemisegment A3 of the indicated genotypes.
Bars show mean  s.e.m. Multiple comparisons were performed using one-way ANOVA with a post hoc Sidak–Bonferroni correction (n.s. = not significant; **P < 0.01;
****P < 0.0001). Bars are labeled with the number of replicates.
Source data are available online for this figure.
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(Haussmann et al, 2016; Lence et al, 2016; Kan et al, 2017). In this
study, we found that m6A controls axonal growth and guidance in
the PNS and CNS, in part by regulating protein levels of two key
components of the cytoskeleton, Futsch, and Profilin, respectively.
Roles for m6A in axonal growth and guidance have been previously
observed in mammals. For instance, depletion of FTO in axons of
dorsal root ganglia neurons represses axon elongation in mouse (Yu
et al, 2018). In this model, FTO depletion inhibits axon growth due
to increased m6A levels on growth-associated protein-43 (GAP-43)
mRNA, resulting in reduced GAP-43 protein abundance. Accord-
ingly, the growth defect can be rescued by expressing a deficient-
m6A construct encoding GAP-43. However, how m6A inhibits GAP-
43 translation is not understood. Perhaps a similar mechanism as
described in our work, involving the recruitment of FMRP, is
operating (see also below). This would be consistent with the upreg-
ulation of GAP-43 observed at synapses of Fmr1 KO mice (Klemmer
et al, 2011). Upon injury of the same dorsal root ganglion neurons,
it was shown that m6A levels increase dramatically, resulting in
enhanced protein synthesis and eventually axon regeneration
(Weng et al, 2018). A similar activity was also observed in the adult
CNS. Thus, m6A plays a positive role in axonal growth upon
injury, which seems in contradiction to its role in normal growth
during development. Nevertheless in mouse embryonic dorsal
spinal cord (DSC), m6A is required for axon growth and guidance
by promoting Robo3.1 translation via YTHDF1 (Zhuang et al, 2019).
Thus, m6A has the ability to either promote or repress axon








Figure 8. Ythdf recruits Fmr1 and repress Futsch translation via m6A.
A futsch genomic region (X1,408,435–1,454,00) and corresponding browser tracks from miCLIP-seq experiments in S2R+ cells. futsch transcripts contain two m6A
peaks in its 5´ UTR, as indicated.
B Schematic of GFP reporter constructs containing an actin promoter and either wild-type 5´ UTR region of futsch or a mutated version (futsch**) containing two-
point mutations (A – T) at the identified m6A sites. mCherry is under the control of a same actin promoter.
C, D RNA immunoprecipitation assay. Quantification of GFP RNA levels upon immunoprecipitation of Myc-tagged Fmr1 or Flag-tagged Ythdf. Bars show average 
SD of technical triplicates (C) or Flag-tagged Fmr1 in the presence of overexpressed HA-tagged Ythdf. Bars show median  s.e.m. of biological triplicates. P-values
were determined with an unpaired, two-tailed Student’s t-test. (n.s. = not significant; **P < 0.01) (D). Rpl15 levels were used as a normalization control and the
enrichment of mCherry is shown as a negative control for background binding.
E–G Representative Western blot analysis of the protein level (E) and quantification of the translation efficiency of S2R+ cells transfected with the wild-type or mutated
futsch reporter constructs upon control or Mettl3 KD (F) or Ythdf KD (G). LacZ dsRNA was used for the control KD. The translation efficiency was calculated as the
ratio of the relative GFP protein level and GFP mRNA level. mCherry served as a normalization control for both the protein and mRNA level. Bars show
mean  s.e.m of biological triplicates. P values were determined with a Student’s t-test. (n.s. = not significant; *P < 0.05; **P < 0.01).
H Model of the interplay between Ythdf and Fmr1 in translation control.
Source data are available online for this figure.
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Ythdf controls axon growth and guidance and interacts
with Fmr1
In mammals, there are three YTHDF proteins that were shown to
control translation and mRNA decay. The current view is that
YTHDF1 stimulates translation and YTHDF2 decreases mRNA stabil-
ity, while YTHDF3 regulates both processes (Patil et al, 2018; Zhao
et al, 2019), even though this model has been challenged recently
(Lasman et al, 2020; Zaccara & Jaffrey, 2020). Thus, more work is
required to appreciate how the three YTH proteins interplay in the
cytoplasm and how much of their functions overlap. In Drosophila,
there is only one Ythdf protein but its function was not character-
ized prior to our work. In fact, the role of cytoplasmic m6A in this
organism has remained enigmatic. Our attempt to demonstrate a
role on mRNA stability in S2R+ cells was not conclusive, so it is
unclear whether m6A regulates this process in flies (data not
shown). The fact that most m6A sites resides in the 5´ UTR, near the
start codon, suggests instead that the main role of cytoplasmic m6A
in Drosophila is to regulate translation. Consistent with this assump-
tion, we found that m6A controls futsch and chic translation through
Ythdf activity. However, in contrast to mammalian YTHDFs, Droso-
phila Ythdf does not activate their translation. It represses transla-
tion of these mRNAs likely via the recruitment of the translation
inhibitor Fmr1. For future studies, it would be interesting to address
whether translation inhibition is the major function of Ythdf in
Drosophila or whether it has a broader role depending for instance
on the nature of its interacting partners. Furthermore, whether such
inhibitory role of YTHDFs in translation also exists in mammals
awaits future investigations.
FMRP was recently shown to bind methylated mRNAs and to
facilitate their export (Edens et al, 2019; Hsu et al, 2019), as well as
to protect them from degradation by preventing YTHDF2 binding
(Zhang et al, 2018). It was proposed to be an m6A reader, acting in
a sequence-dependent context. Indeed, in vitro pull down as well as
FMR1 CLIP demonstrated association to GGACA/C/U sequence,
with clear enrichment upon methylation (Arguello et al, 2017;
Edupuganti et al, 2017; Hsu et al, 2019). Whether this enrichment is
due to direct recognition of the methyl group by FMR1 or to a
change in RNA accessibility is still unclear. Replacing the first or the
second G by A strongly decreased FMR1 association, while no effect
was observed on YTH binding. Here we show that similar rules
apply in Drosophila. In addition, our data further demonstrate that
Ythdf interacts directly with Fmr1 and stabilizes its interaction to
RNA. This direct interaction appears essential for both protein activ-
ities in the context of axonal growth. Of note, human YTHDF2 was
recently shown to be in a same complex with FMR1, suggesting that
this mode of interaction is conserved (Zhang et al, 2018).
Relevance of this interplay in FXS
The absence of FMRP leads to the FXS, which is a severe inherited
neuronal disorder that currently lacks efficient therapeutic treat-
ment. The phenotype of the patients suffering from FXS is often
complex, accompanied by an increase in autism spectrum disorder
specific traits and other features like delayed motor development,
hyperactivity, aggression, and epileptic seizures (reviewed in refs.
Hagerman et al, 2002; Garber et al, 2008; Utari et al, 2010; Santoro
et al, 2012; Hagerman et al, 2014; Kidd et al, 2014; Maurin et al,
2014; Schaefer et al, 2015; Dahlhaus, 2018). These abnormalities
result from defects in neuronal development and maturation. Inter-
estingly, the phenotypes of Fmr1 mutants are reminiscent of the
pathological symptoms of FXS patients and, consequently, Droso-
phila has been widely used to learn the basic mechanisms underly-
ing FMRP functions and to test the efficacy of drug treatment
(Drozd et al, 2018). In particular, the increased synapse arborization
and bouton number at the NMJ recall the dendritic spine over-
growth observed in FXS patients. Moreover, expressing human
FMR1 in Drosophila Fmr1 null mutants rescues the overgrowth at
the NMJ and the defect in the brain, highlighting the functional
conservation of the two orthologues (Coffee et al, 2010). Since
FMR1 is involved in different functions such as splicing, nuclear
export, and translation, it remained unclear which activity was more
relevant in the FXS etiology. A clue came when treatment with the
translation inhibitor puromycin could rescue several aspects of FXS,
including the locomotion phenotype and the overgrowth at the
NMJ, suggesting that it was an excess of translation that yields these
defects (Stefani et al, 2004; Bolduc et al, 2008; Kashima et al, 2017).
Accordingly, the first target identified for Fmr1 was Futsch, a micro-
tubule-associated protein orthologue of mammalian MAP1B (Zhang
et al, 2001). Fmr1 negatively regulates futsch translation, and this is
necessary to prevent NMJ overgrowth. Importantly, this function
was also found in mice (Lu et al, 2004). Our data showing that
Fmr1 may repress translation via m6A activity links m6A to some
aspects of the FXS studied in the fly model. It would be of critical
importance to test whether a similar mechanism also applies to
mammals. The FMR1-mediated nuclear export and stability of
methylated RNA as recently uncovered may contribute as well to
the disease (Zhang et al, 2018; Edens et al, 2019; Hsu et al, 2019). It
is worth mentioning that while our study mainly focuses on two key
Fmr1 targets involved in the gross morphology of the nervous
system, it is likely that m6A and Fmr1 regulate additional targets
involved in more subtle processes such as synapse functionality and
complex trait behaviors.
In conclusion, our study indicates that m6A modulates both CNS
and PNS development by restricting axonal growth and promoting
correct assembly of the neural circuits. These functions are reminis-
cent to the functions of Fmr1 in the nervous system, and our work
shows that both m6A and Fmr1 tightly cooperate to regulate these
processes. We foresee that this new knowledge will open new
avenues for the design of complementary treatments of FXS.
Materials and Methods
Drosophila stocks
The stocks used are the following: Fmr1Delta50M, Fmr1Delta113M,
chic221, futschN94, Mettl14Df, Ythdc1Df, Tub-GAL4, Elav-Gal4,
c772Gal4:UAS-CD8-GFP, Elav-Gal4;;UAS-FMR1-GFP/TM3 (Blooming-
ton Stock Collection), Mettl3null, Mettl3Deltacat, UAS-Mettl3, Mettl14fs,
Ythdc1DeltaN (Lence et al, 2016), Mettl3SK2, Mettl14SK1 (kind gift from
Eric Lai), P(GD9882)v20969/TM3 (VDRC), P(GD9882)v20968/TM3
(VDRC), w1118;P(GD11887)v27577 (VDRC), w1118;P(GD16300)
v48560 (VDRC), and w1118 (kind gift from Paola Bellosta).
Drosophila melanogaster Canton-S with mutant alleles for Ythdf
were generated using the CRISPR/Cas9 system, as described
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previously (Lence et al, 2016). Guide RNA sequences used were
CTTCGGATAAATTCTTTCCGAATA and AAACTATTCGGAAAGAAT
TTATCC as well as CTTCGGGCGAGTGGGGCAGGCGCG and
AAACCGCGCCTGCCCCACTCGCCC. The first allele (Ythdf#0)
produces a deletion of 1,221 nucleotides in the coding sequence,
deleting residues 172–557, that includes the whole YTH domain.
The second allele (Ythdf#2) is a deletion of 1319 nucleotides and
removes residues 162–558.
Drosophila cell lines
Drosophila S2R+ are embryonically derived cells obtained from the
Drosophila Genomics Resource Center (DGRC; Flybase accession
FBtc0000150), while Drosophila BG3 cells are derived from central
nervous system of third instar larvae (DGRC; Flybase accession
FBtc0000068). Mycoplasma contamination was not detected (veri-
fied by analyzing RNA sequencing data).
Immunohistochemistry
For the immunohistochemistry in adult and pupal brains, the
following protocol was used: Brains were collected in cold PBS
and subsequently fixed for 10 min in 4% formaldehyde (in PBS
0.3% Triton X-100). Upon three washes in PBS 0.3% Triton X-
100, the brains were blocked in 10% BSA (in PBS 0.3% Triton X-
100) for 1 h rocking at RT. After this step, the brains were incu-
bated overnight at 4°C with the primary antibody appropriately
diluted in blocking solution. The second day, the samples were
washed 3 times in PBS 0.3% Triton X-100 and then incubated
with the appropriate secondary antibody diluted in blocking solu-
tion for 1h at RT. Upon three washes in PBS 0.3% Triton X-100,
the brains were mounted and kept at 4°C for imaging. Primary
antibody used were as follows: anti-FasII 1/50 (ID4 Hybridoma
Bank) and anti-GFP 1/500 (Invitrogen A11122). Secondary anti-
body used were Alexa Fluor 555 Donkey anti-Mouse and Alexa
Fluor 488 Goat Anti-Rabbit at a dilution of 1/500. Images were
acquired on a Leica TCS SP8 laser scanning confocal microscope
or on a Leica DM6000CS confocal microscope and processed using
FijiTM software.
NMJ analysis
For NMJ staining, third instar larvae were dissected in cold PBS and
fixed with 4% paraformaldehyde in PBS for 45 min. Larvae were
then washed in PBS-T (PBS + 0.5% Triton X-100) six times for
30 min and incubated overnight at 4°C with the following primary
antibodies: mouse anti-synaptotagmin, 1:200 (3H2 2D7, Develop-
mental Studies Hybridoma Bank, DSHB) and TRITC-conjugated
anti-HRP, 1:1,000. After six 30-min washes with PBS-T, secondary
antibody anti-mouse conjugated to Alexa-488 was used at a concen-
tration of 1:1,000 and incubated at room temperature for 2 h.
Larvae were washed again six times with PBS-T and finally
mounted in Vectashield.
Images from muscles 6–7 (segment A2–A3) were acquired with a
Leica Confocal Microscope SP5. Serial optical sections at
1,024 × 1,024 pixels with 0.4 µm thickness were obtained with the
×40 objective. Bouton number was quantified using Imaris 9 soft-
ware. ImageJ software was used to measure the muscles area and
the NMJ axon length and branching. Statistical tests were performed
in GraphPad (PRISM 8).
RNA probe pulldown
For RNA probe pulldown in BG3 cells, cells were washed with
DPBS, harvested, and pelleted for 10 min at 400 g. The cell pellet
was resuspended in lysis buffer (10 mM Tris–HCl at pH 7.4,
150 mM NaCl, 2 mM EDTA, 0.5% NP-40, 0.5 mM DTT, protease
inhibitor) and rotated head over tail for 15 min at 4°C. Nuclei were
collected by 10-min centrifugation at 1,000 g at 4°C, resuspended in
300 ll of lysis buffer, and sonicated with 5 cycles of 30 s ON, 30 s
OFF low power setting. Cytoplasmic and nuclear fractions were
joined and centrifuged at 18000 g for 10 min at 4°C to remove
the remaining cell debris. Protein concentration was determined
by Bradford, and 1 mg lysate was used for the following
pulldown procedure.
For RNA probe pulldown using purified recombinant proteins,
the indicated amounts of purified proteins were resuspended in
binding buffer (2% Triton X, 20 mM Tris–HCl, 10 mM EDTA,
120 mM NaCl, 50 mM KCl, 1 mM DTT, protease inhibitor) and used
for the following pulldown procedure. Purified proteins were incu-
bated with 1 µg of biotinylated RNA probe coupled to 20 µl Dyna-
beads MyOne Streptavidin C1 (Thermo Fisher) in 600 µl lysis buffer
at 4°C for 1 h rotating head over tail. The beads were washed three
times with lysis buffer and bound proteins eluted by incubation in
1x NuPage LDS supplemented with 100 mM DTT for 10 min at
70°C. Eluted proteins were analyzed by PAGE followed by
Coomassie staining, immunoblotting using the corresponding anti-
bodies or proceeded to quantitative proteomic analysis.
Expression and purification of recombinant proteins
N-His6-tagged NT-Fmr1 (220-684) and N-GST-tagged Ythdf (full
length) were expressed from pQIq-His6 and pGEX-6P-1, respec-
tively, in E. coli BL21(DE3) RosettaTM 2pLysS (Novagen). Cells were
grown in LB-Luria at 37 °C and 160 rpm to an OD600 of 0.6–0.8 and
chilled on ice, and expression was induced by addition of IPTG
(1 mM). Cells were further incubated at 18 °C and 160 rpm for
20 h, harvested by centrifugation for 15 min at 4,000 g at 4°C, and
directly processed for purification: Cells were resuspended in lysis
buffer (50 mM Tris–HCl pH 8.0, 500 mM NaCl, 15 mM imidazole,
5% glycerol, 1 mM DTT, 1 mM MgCl2, Benzonase 1:2,500, protease
inhibitors) and lysed by sonification. Lysates were cleared by
centrifugation (45,000 g, 30 min, 4 °C). For GST-Ythdf purification,
additional 500 mM of NaCl and subsequently 0.2% of polyethyle-
neimine (40 kDa) was added to the cleared lysate, incubated for
10 min at 4°C, and centrifuged at 4000 g for 10 min in order to
precipitate nucleic acids. Proteins were captured from cleared
lysates using a HisTrap FF 5 ml (His-NT-Fmr) or GstTrap FF 5 ml
column (GST-Ythdf; both GE Healthcare) according to the manufac-
turer’s instructions and using a Biorad NGC Quest FPLC system.
Fractions containing the respective recombinant proteins were
pooled and concentrated using Amicon Ultra-15 spin concentra-
tors with 10 kDa cutoff (Merck Millipore). Concentrated protein
pools were injected onto a Superdex 200 16/60 pg in gel filtration
buffer (25 mM Tris-Cl pH 7.5, 500 mM NaCl, 1 mM DTT, 10% glyc-
erol). Peak fractions containing the recombinant proteins were
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pooled, aliquoted, and snap-frozen in liquid nitrogen. Frozen
aliquots were stored at 80°C.
TRIBE
TRIBE was performed as previously described (McMahon et al,
2016; Xu et al, 2018; Worpenberg et al, 2019). Briefly, for the identi-
fication of mRNA targets in S2R+ cells, Flag-tagged Ythdf and Fmr1
versions fused to the catalytic domain of Adar (cdAdar) were ectopi-
cally expressed using a metal-inducible expression system. Forty-
eight hours after protein expression induction, the cells were
washed with DPBS and harvested.
For the identification of in vivo targets, 3rd instar larvae express-
ing a Flag-tagged version of Ythdf fused to cdAdar driven by Elav-
Gal4 were collected and the brains dissected and collected in PBS.
For protein expression analysis, 50% of the cells/brains were resus-
pended in lysis buffer (50 mM Tris–HCl at pH 7.4, 150 mM NaCl,
0.5% NP-40, protease inhibitor) and incubated for 30 min on ice. Cell
debris was removed by centrifugation for 5 min at 12,000 g at 4°C and
the expression analyzed by immunoblotting using anti-Flag antibody.
For the identification of editing events, the remaining 50% of
cells were used for total RNA isolation using TRIzol reagent, mRNA
was purified by two rounds of Oligo(dT) selection using Dynabeads,
and the purified mRNA was used for Illumina Next-generation
sequencing library preparation using NEBNext UltraTM II RNA
Library Prep Kit for Illumina according to manufacture protocol.
From the TRIBE data analysis, the score is defined as a log-
likelihood ratio of two conditions and, therefore, describes how
different conditions are (the higher the Score, the more different
the A-I editing). The arbitrary SumScore cutoff used in this manu-
script is 20 to exclude low confidence targets and background
from our analysis.
Co-immunoprecipitation
S2R+ cells were transfected using Effectene transfection reagent with
plasmids expressing the indicated constructs. After 72 h, the cells
were washed with DPBS, harvested, and pelleted by centrifugation
for 3 min at 1,000 g. The cell pellet was resuspended in 1 ml lysis
buffer (50 mM Tris–HCl at pH 7.4, 150 mM NaCl, 0.5% NP-40)
supplemented with protease inhibitors and incubated for 30 min on
ice. The cell debris was removed by centrifugation at 12,000 g for
5 min at 4°C, and the protein concentration of the cleared lysate
was measured by Bradford. Two mg protein lysate was combined
with 2 ll antibody coupled to 20 ll Protein G Dynabeads in lysis
buffer and incubated rotating head over end at 4°C for 2 h. The
beads were washed three times for 10 min with lysis buffer and the
proteins eluted in 1× NuPage LDS buffer supplemented with
100 mM DTT by incubation for 10 min at 70°C. The eluted proteins
were either analyzed by Western blot or conducted to quantitative
proteomics analysis.
RNA immunoprecipitations (RIP)
For RIP from cell lysate, S2R+ cells were transfected with the plas-
mids expressing the indicated constructs. After 72 h, the cells were
washed with DPBS, harvested, and pelleted by centrifugation for
3 min at 1,000 g. The cell pellet was resuspended in 1 ml lysis
buffer (50 mM Tris–HCl at pH 7.4, 150 mM NaCl, 0.5% NP-40)
supplemented with protease inhibitors and RNase inhibitor.
For RIP from Drosophila larvae, 30 larvae with the indicated
genotype were collected in DPBS on ice, carefully washed by
exchanging the DPBS two times, and lysed by squishing with a
pestle in 1 ml lysis buffer. The resuspended cell pellet or larvae
lysate was incubated for 30 min on ice. The cell debris was removed
by centrifugation at 12,000 g for 5 min at 4°C, and the protein
concentration of the cleared lysate was measured by Bradford. Two
mg protein lysate was combined with 2 ll antibody coupled to 20 ll
Protein G Dynabeads in lysis buffer and incubated rotating head
over end at 4°C for 2 h. The beads were washed three times for
10 min with lysis buffer. 20% of the beads were used for the elution
of protein–RNA complexes by incubation in 1× NuPage LDS buffer
supplemented with 100 mM DTT for 10 min at 70°C. The eluted
proteins were analyzed by Western blot. 80% of the beads were
used to extract RNA using TRIzol reagent. The enrichment of the
transcripts was analyzed by qPCR and the fold change calculated by
normalizing the transcript levels in the pulldown fractions to the
corresponding input and a control pulldown.
For RIP from pupal heads for endogenous Fmr1: 200 heads per
each genotype were collected in PBS on ice and subsequently resus-
pended in 100 ll of lysis buffer (10 mM Tris–HCl pH 7.4, 140 mM
NaCl, 0.5% Triton X-100, 1 mM DTT, 2 mM EDTA) supplemented
with protease, phosphatase, and RNase inhibitors. The heads were
lysed with a motor pestle and left on ice for 20’. The cell debris was
removed by centrifugation at 12,000 g for 10 min at 4°C, and 1/10
of the volume was taken as an input and kept at 80, while the rest
of the supernatant was divided in two and combined with either
20 ll of anti-Fmr1 5B6 and 20 ll of anti-Fmr1 5A11 or to 1.5 ll of
mouse IgG together with 50 ll of Protein G Dynabeads in lysis
buffer.. The lysate was incubated with the beads antibody rotating
head over end at 4°C overnight. The day after, the beads were
washed three times for 10 min and subsequently resuspended in
100 ll of lysis buffer that were further treated with 40 µg of protei-
nase K for 30’ at 55°C. Upon treatment, the supernatant was sepa-
rated from the beads and RNA was extracted using TRIzol reagent.
The enrichment of transcripts was analyzed by qPCR and the fold
change calculated by normalizing the transcript levels in the pull-
down fractions to the corresponding input and a control pulldown.
For the RIP with overexpressed Ythdf-HA, 3 µg of anti-HA (Santa
Cruz sc-805 rabbit polyclonal) was conjugated to 50 µl of Protein G
Dynabeads and used to immunoprecipitate tagged Ythdf from 50
adult heads. For the RIP with overexpressed Fmr1-GFP, 25 µl of
GFP Trap_MA beads (Chromtek) was used to immunoprecipitate
tagged Fmr1 from 50 adult heads.
Sequencing and bioinformatics analysis of RNA
immunoprecipitation from Drosophila heads
Strand-specific, rRNA-depleted libraries were generated with the
Ovation SoLo RNA-Seq System plus Drosophila AnyDeplete Probe
Mix (Tecan Genomics). Each individual library was quantified and
quality controlled using Qubit Fluorometer (Thermo Scientific),
LabChip GX (Perkin Elmer). After libraries equimolar pooling, the
final pool was quality checked again with Qubit, LabChip GX, and
also qPCR (KAPA and BIORAD). The adaptor-tagged pool of
libraries was sequenced in the Illumina Novaseq6000 in CIBIO NGS
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Core facility, using the Ovation SoLo Custom R1 primer and produc-
ing 960 million of reads. Reads were preprocessed (quality < Q30,
adapters stripped) with TrimGalore (https://www.bioinformatic
s.babraham.ac.uk/projects/trim_galore/) and then aligned to the
Drosophila melanogaster genome r6.28 with STAR (Dobin et al,
2013). Gene read counts were normalized by library size. RIP fold
enrichment and P-value were computed for each condition with
DESeq2 (Love et al, 2014) as (RIP / INPUT) or (IGG / INPUT).
Genes and transcripts significantly enriched (adjusted P-
value <= 0.05) in the RIP/INPUT and not in the corresponding IGG/
INPUT were considered to be Fmr1 targets. Functional enrichment
of Fmr1 targets was computed with Panther (Mi et al, 2019) and
plotted with ReviGO (Supek et al, 2011). Overlap P-value was
computed using hypergeometric test.
In vitro RNA interaction studies (Electro Mobility Shift Assay—
EMSA and Fluorescence Polarization—FP)
Cy5-labeled RNA probes (Horizon Discovery, 10 nM in EMSA and
5 nM in the FP) were incubated with varying concentrations of
His-NT-Fmr1 and/or GST-Ythdf (300 nM in EMSA and 2.5 nM to
2.5 µM in FP) at a total volume of 10 µl in interaction buffer
(20 mM Tris-Cl pH 7.5, 150 mM NaCl, 10% glycerol, 1 mM EDTA,
1 mM DTT). The probes and proteins were incubated for 10 min
at room temperature. For EMSA, the samples were mixed with
2 µl of 6 × loading buffer (60% Glycerol, 20 mM Tris-Cl pH 8.0,
60 mM EDTA) and loaded onto a 12% TBE-PA-Gel. The gel was
run for 45 min at 200 V in TBE buffer and scanned using a
Typhoon FLA 9000 @ 635 nm to visualize the fluorescence of the
Cy5-labeled RNA probes. For FP measurements, samples were
transferred to a 384-well plate (CorningTM, Low-Volume, Poly-
styrene, black) and fluorescence polarization of the Cy5-labeled
oligos was analyzed on a Tecan Spark 20M plate reader at 20°C
(excitation wavelength: 625 nm, emission wavelength: 665 nm,
gain: 125, flashes: 15, integration time: 40 µs). Relative fluores-
cence polarization was calculated by subtracting the FP value of
the oligo-only conditions from all conditions that contained vari-
able amounts of His-NT-Fmr1 and/or GST-Ythdf. The relative FP
values from three independent experiments including standard
deviation were plotted using GraphPad Prism 8. Binding constants
(kd values) were determined by fitting a Michaelis–Menten non-
linear regression onto the relative FP values in GraphPad Prism 8,
if applicable.
Cell culture
Drosophila melanogaster S2R+ and BG3 cells were cultured in
Schneider’s Drosophila media (PAN BIOTECH) supplemented with
10% FBS and 1% penicillin–streptomycin. The culture medium for
BG3 cells was additionally supplemented with 10 µg/ml insulin.
Plasmid transfections were achieved using Effectene transfection
reagent (Qiagen) according to the manufacture’s protocol. The
knockdown was achieved using dsRNA. The PCR templates for the
dsRNA were prepared using T7 megascript Kit (NEB). 2 Mio S2R+
cells were seeded in 6-well plates and treated 6h in serum-free
medium with 15 lg of dsRNA. Afterward, medium containing 10%
FBS and 1% penicillin–streptomycin was added to the cells. dsRNA
treatment was repeated after 48 and 96 h.
Reporter assay
2 Mio cells were seeded 24 h before the transfection of the indicated
reporter plasmids. Twenty-four h after transfection, the cells were
harvested. One half was used for RNA extraction followed by RT–
qPCR to determine the relative GFP level normalized to the mCherry
level. The second half was used for Western blot analysis as
described. The relative GFP protein level was determined by
normalization to the mCherry protein level. The translation effi-
ciency was determined by normalizing the relative GFP protein level
to the relative GFP mRNA level.
RNA isolation and quantitative real-time PCR analysis
Total RNA from S2R+ cells or larval brains was isolated using TRIzol
reagent according to the manufacturer protocol, DNA contamination
removed by DNase-I (NEB) treatment and reverse-transcribed using
M-MLV reverse transcriptase (Promega). The transcript levels were
quantified by real-time PCR using Power SYBR green Master Mix.
Rpl15 mRNA and 18S rRNA were used as housekeeping control
genes.
Total RNA from head lysates was isolated using TRIzol reagent
according to the manufacturer protocol and reverse-transcribed
using RevertAid First Strand cDNA Synthesis Kit. The transcript
levels were quantified by real-time PCR using Power SYBR green
Master Mix. RP49 and Tubulin RNA were used as housekeeping
control genes.
Western blot analysis
Proteins were extracted for 30 min on ice, the lysates were centri-
fuged at 12,000 g for 5 min at 4°C, and protein concentration in the
supernatant was determined by Bradford. For Futsch protein detec-
tion, lysates were additionally dephosphorylated using Lambda
protein phosphatase (NEB) following manufacturer’s instructions.
Protein samples were separated on SDS–PAGE gels. Wet transfer to
nitrocellulose membrane (Whatman) was performed for 90 min at
100 V. Membranes were blocked for 30 min in 5% non-fat dry milk
and PBS–0.5% Tween 20 (PBS-T) and incubated with primary anti-
bodies overnight at 4°C: anti-Profilin chi1J 1/500 (Hybridoma
Bank), anti-Actin I-19 (Santa Cruz sc-1616), and anti-Futsch 22C10
(Hybridoma Bank). Signal was detected with corresponding HRP-
conjugated secondary antibodies and ECLTM Prime Western Blotting
Detection Reagent or ECLTM Select Western Blotting Detection
Reagent (Amersham).
GST pulldown
Recombinant GST-tagged Ythdf or GST (2 µM final) were mixed
with recombinant His6-tagged NT-Fmr1 (2 µM final) in 100 µl bind-
ing buffer (20 mM Tris-Cl pH 7.5, 150 mM NaCl, 10% glycerol,
0.1% Triton X-100, 1 mM DTT) and incubated for 1 h rotating head
over end at 4°C with 20 µl Glutathione Sepharose beads. The beads
were washed once with binding buffer +1% Triton X-100 and two
subsequent times with binding buffer. Bound proteins were eluted
by incubation in 50 µl 1× NuPage LDS supplemented with 100 mM
DTT for 5 min at 95°C. Input and pulldown samples were analyzed
by SDS–PAGE and subsequent coomassie brilliant blue staining.
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TRAP
TRAP was performed as previously described (Thomas et al, 2012).
Briefly, Drosophila melanogaster 3rd instar larvae expressing Elav-
Gal4 driven GFP-tagged Rpl10Ab or cytoplasmic GFP in a wild-type
and Ythdf mutant background were collected and lysed in extraction
buffer (20 mM HEPES, pH 7.5, 150 mM KCl, 5 mMMgCl2, 1% Triton
X-100, 0.5 mM DTT, 100 µg/ml Cycloheximide, 100 U/ml Rnase
inhibitor, Protease Inhibitor). Cell debris was removed by centrifuga-
tion at 12,000 g for 5 min at 4°C and the protein amount determined
by Bradford. Twomg lysate was combined with 20 ll Protein G Dyna-
beads conjugated to anti-GFP antibody and incubated at 4°C for 2 h
followed by three washing steps in Wash Buffer (150 mM NaCl,
0.05% Triton X-100, 50 mM Tris, 5 mM MgCl2, and 40 U/ml RNase
inhibitor) at 4°C. RNA was extracted using TRIzol reagent following
manufacture’s protocol and the enrichment of the transcripts
analyzed by qPCR.
m6A-miCLIP
miCLIP was performed following previously described method (Lin-
der et al, 2015) using 10 lg of purified mRNA from Drosophila S2R+
cells and 5 lg of anti-m6A antibody (Synaptic Systems, Lot# 202003/
2-82). Immunoprecipitations were performed in quadruplicates, and
as a control, one immunoprecipitation was performed where UV-
crosslinking was omitted. Of note, this sample produced a library of
limited complexity, reflecting a low amount of background mRNA
binding. Briefly, total RNA was isolated using Trizol reagent (Invitro-
gen) and DNA was removed with DNase-I treatment (NEB).
Polyadenylated RNA was purified by two rounds of binding to Oligo
(dT)25 magnetic beads (NEB), and mRNA was fragmented with RNA
fragmentation solution (Ambion) using 1 ll of solution per 2 lg of
mRNA and with 7-min incubation at 70°C. Immunoprecipitation was
performed at 4°C in 500 ll of binding buffer (BB) (50 mM Tris–HCl
pH 7.4, 150 mM NaCl, 0,5 % NP-40). First, isolated mRNA and anti-
body were incubated for 2 h. Samples were then transferred to indi-
vidual well of a 12-well cell culture plate and crosslinked on ice (two
times at 150 mJ/cm2). Next, 60 ll of magnetic ProteinG beads (Invit-
rogen) was resuspended in 500 ll of BB and added to the IP sample.
Samples were then incubated for additional 2 h at 4°C, before wash-
ing with ice-cold solutions was performed: 1x with BB, 2x with high
salt buffer (50 mM Tris–HCl pH 7.4, 1 M NaCl, 1% NP-40, 0,1%
SDS), 1x BB , 2x with PNK buffer (20 mM Tris–HCl pH 7.4, 10 mM
MgCl2, 0,2% Tween). All washes were performed by gentle pipetting
and with 1-min incubation on ice. Washes with HSB were addition-
ally rotated for 2 min at 4°C. Finally, beads were resuspended in
900 ll of PNK buffer. Forty ll was used for WB analysis to evaluate
immunoprecipitation efficiency. Remaining 860 ll was used for
library preparation. All steps of library preparation were performed
as previously described in (Sutandy et al, 2016). Libraries were
sequenced on an Illumina NextSeq500.
For the miCLIP fragmented input control library, fragmented
mRNA, that was also used for miCLIP IP, was first purified using
the 1.8× volume of RNAClean XP beads (Beckman Coulter). Follow-
ing the 20-min incubation at RT, captured RNA was washed 3x with
80% EtOH and eluted in 20 ll of RNase-free water. The library was
prepared using ~ 50 ng of cleaned, fragmented mRNA using the
NEBNext Ultra Directional RNA Library Prep Kit for Illumina (NEB),
by omitting the RNA fragmentation step and following the manufac-
turer‘s protocol. For library amplification, 11 PCR cycles were used
and indicated primer and adaptor sequences: NEBNext Index 27
Primer for Illumina: 5´-CAAGCAGAAGACGGCATACGAGATAAAG
GAATGTGACTGGAGTTCAGACGTGTGCTCTTCCGATC-s-T-3´
(Expected index read: ATTCCT), NEBNext Adaptor for Illumina:
5´-/5Phos/GAT CGG AAG AGC ACA CGT CTG AAC TCC AGT CUA
CAC TCT TTC CCT ACA CGA CGC TCT TCC GAT C-s-T-3´. Libraries
were sequenced on an Illumina NextSeq500.
m6A-miCLIP analysis
Sequencing qualities were checked for all reads using FastQC (ver-
sion 0.11.5; https://www.bioinformatics.babraham.ac.uk/projects/
fastqc/). Afterward, reads were filtered based on sequencing quali-
ties (Phred score) of the barcode region. Reads with more than one
position with a Phred score < 20 in the experimental barcode (posi-
tions 4 to 7 in the reads) or any position with a Phred score < 10 in
the random barcode (positions 1 to 3 and 8 to 9) were excluded
from the subsequent analysis. Remaining reads were de-multiplexed
based on the experimental barcode (positions 4–7) using Flexbar
(v3.0.0) (Dodt et al, 2012) without allowing any mismatch.
Individual samples were processed using the CLIP Tool Kit (CTK)
v1.0.9. (Shah et al, 2017). We largely followed recommended user
guide lines specific to CTK iCLIP data analysis as described here
(https://www.zhanglab.c2b2.columbia.edu/index.php/ICLIP_data_a
nalysis_using_CTK). Briefly, 3’adapter sequences [AGATCGGAA-
GAGCGGTTCAG] were trimmed using cutadapt v1.8. [overlap = 5; -m
29] (Martin, 2011). PCR duplicates were removed using a custom perl
script, followed by the extraction of the 9 nucleotide miCLIP barcode
and its addition to the read name. All cDNA libraries were filtered for
common Drosophila virus sequences (Webster et al, 2016) using
bowtie v1.1.2 [-p 4 -q (-X 1000) --fr best]. Next, to avoid sequencing
read alignment software biases, we decided to map sequencing reads
to the Drosophila melanogaster dm6 genome assembly (ensemble v81)
using novoalign (http://www.novocraft.com/), bwa (Li & Durbin,
2009), and STAR v2.4.2a (Dobin et al, 2013). For STAR alignments, we
used a custom python script to transform sam files into the expected
format for downstream CITS identification. For STAR alignments, we
did not consider spliced reads, soft-clipped reads, mismatches and
indels near read start and read end, and reads withmore than one indel
or mismatch. Then, unique tags were identified using parseAlign-
ment.pl [-v --map-qual 1 --min-len 18 --indel-to-end 2] to extract unique
tags, followed by read collapsing using tag2collapse.pl. [-v -big
--random-barcode -EM 30 --seq-error-model alignment -weight --weight-
in-name --keep-max-score --keep-tag-name]. Crosslinking induced
mutation sites (CIMS) indicative for the antibody-m6A interaction
were identified running CIMS.pl [-big -n 10], and CIMS with
FDR < 0.001 were retained. Crosslinking induced truncations sites
were identified using CITS.pl [-big -p 0.001 --gap 25]. Sites spanning
more than 1 nucleotide were removed.
We further filtered identified CIMS and CITS to be reproducible in
at least 2 out of 4 replicate m6A immunoprecipitation samples and not
present in identified CITS from the input control sample for each
aligner separately. Moreover, CIMS were filtered to have a minimum
of 6 unique tags [k > 5], at least three unique substitutions [m > 2],
and be prevalent in less than 20% of the coverage [m/k < 0.2] to
avoid calling homozygous and heterozygous single nucleotide
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variants. CIMS sites were found to be almost exclusive C-to-T conver-
sions (n = 6,225, 88%  5.8%) independent of the alignment soft-
ware used (3 aligners n = 2677, 2 n = 2411, 1 n = 1137). For a
stringent CITS set, we filtered CITS sites (n = 22,917) that mostly
truncated at A residues (n = 11,897, 52%) and were followed by C
residues (CITS-AC; n = 6,799, 57%). Two thousand three hundred
and two (37%) of C-to-T CIMS overlapped within a 1nt window to
CITS-AC sites, suggesting that in many cases the same nucleotide was
identified. Together, we considered a set of 13,024 C-to-T conversions
CIMS and AC truncation CITS across 2,464 genes for our final S2 cell
miCLIP data set. CITS site were annotated as described before (Wes-
sels et al, 2019). For representation purposes, we simplified the anno-
tation categories. All CITS not annotated to 5’UTR, CDS, 3’UTR, or
intron were summarized in the category “other”. Enrichments were
calculated relative to median feature proportions (5’UTR = 0.08
(131nt), CDS = 0.78 (1309.5nt), 3’UTR = 0.14 (234nt)) determined
previously for S2 cells (Wessels et al, 2019). Enrichments for sites
annotated as intronic were set to 1.
SELECT
SELECT was performed as described previously (Mao et al, 2019).
Briefly, 1 lg total RNA of isolated 3rd instar larval brains of the indi-
cated genotypes was diluted in 5 lM dNTPs, 40 nM up and 40 nM
down primers (m6A_1 up: TAGCCAGTACCGTAGTGCGTGTTGGTTT
TGGTTTGGGTG; m6A_1 down: CTTTCTTTGGTTTTGGTTAATAAC
TCAGAGGCTGAGTCGCTGCAT; m6A_2 up: TAGCCAGTACCGTAGT
GCGTGGTTTTTTTTCGACTTTGCTTAATTG; m6A_2 down: CTTTC
GGTTTTTGGTTTTGTTCAGAGGCTGAGTCGCTGCAT; Control up: T
AGCCAGTACCGTAGTGCGTGGTTTTTTTTCGACTTTGCTTAATTGT;
Control down: TTTCGGTTTTTGGTTTTGTTTCAGAGGCTGAGTCGC
TGCAT), targeting the m6A or a control site one nucleotide
upstream of the m6A_2 site on futsch, and 1 × CutSmart buffer
(NEB) to 17 ll. Annealing of primers was performed for 1 min at
each 90°C, 80°C, 70°C, 60°C, 50°C, and 6 min at 40°C. Afterward,
0.01U Bst 2.0 DNA polymerase, 0.5U SplintR ligase and 10 nmol
ATP was added in a total volume of 3 ll and incubated for 20 min at
40°C and 80°C. qPCR for quantification was carried out using 4 ll of
SELECT reaction in a 20 ll reaction volume using SYBR green. Rela-
tive SELECT products were calculated by normalization to the RNA
abundance determined by the control site and the wild-type control.
Statistics
Multiple comparisons of the NMJ phenotypes were performed using
one-way ANOVA with a post hoc Sidak–Bonferroni correction
(n.s. = not significant; *P < 0.05; **P < 0.01; ***P < 0.001;
****P < 0.0001). P values of Western blot quantification, RIP experi-
ments, and SELECT were determined with an unpaired, two-tailed
Student’s t-test. (n.s. = not significant; *p < 0.05; **p < 0.01;
***p < 0.001; ****p < 0.0001). The significance of the overlap of the
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